JRCT ID: jRCT2080220039
Registered date:06/09/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Cancer |
Date of first enrollment | 06/09/2005 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : C13-URA INN of investigational material : Therapeutic category code : 729 Other diagnostic agents (except extracorporeal diagnostic medicines) Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Efficacy, Safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 84age old |
Gender | |
Include criteria | Patients aged 20 years or older to less than 85 years (at the time of informed consent) |
Exclude criteria |
Related Information
Primary Sponsor | Otsuka Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050039 |
Contact
Public contact | |
Name | |
Address | 03-3257-6599 |
Telephone | |
Affiliation | Otsuka Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |